NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 874 filers reported holding NOVARTIS A G in Q3 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,503,000 | -72.5% | 19,040 | -71.2% | 3.43% | -18.3% |
| Q2 2016 | $5,464,000 | +37.9% | 66,223 | +21.1% | 4.20% | +63.8% |
| Q1 2016 | $3,961,000 | -19.5% | 54,676 | -4.4% | 2.56% | -12.7% |
| Q4 2015 | $4,923,000 | -12.7% | 57,213 | -6.7% | 2.93% | -11.7% |
| Q3 2015 | $5,636,000 | -26.0% | 61,315 | -20.8% | 3.32% | -15.2% |
| Q2 2015 | $7,617,000 | +2.1% | 77,457 | +2.4% | 3.92% | -1.8% |
| Q1 2015 | $7,458,000 | -16.3% | 75,630 | -21.3% | 3.99% | -0.8% |
| Q4 2014 | $8,906,000 | -29.5% | 96,114 | -28.4% | 4.02% | -17.5% |
| Q3 2014 | $12,641,000 | +3.1% | 134,291 | -0.9% | 4.88% | +13.9% |
| Q2 2014 | $12,264,000 | +8.4% | 135,474 | +1.8% | 4.28% | +4.4% |
| Q1 2014 | $11,316,000 | -12.3% | 133,100 | -17.1% | 4.10% | -11.3% |
| Q4 2013 | $12,898,000 | +3.8% | 160,469 | -0.9% | 4.62% | -3.0% |
| Q3 2013 | $12,423,000 | +3.7% | 161,954 | -4.4% | 4.76% | +2.5% |
| Q2 2013 | $11,982,000 | – | 169,450 | – | 4.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |